Approved Products
CLEAR

HK-Approved Biosimilar Products

amgevita

  • AMGEVITATM solution for injection in pre-filled pen 40mg/0.8ml
  • AMGEVITATM solution for injection in pre-filled syringe 40mg/0.8ml
(adalimumab biosimilar)

Kanjinti

  • KANJINTI® powder and solvent for concentrate for solution for infusion 420mg
  • KANJINTI® powder for concentrate for solution for infusion 150mg
(trastuzumab biosimilar)

mvasi

  • MVASI™ concentrate for solution for infusion 100mg/4ml
  • MVASI™ concentrate for solution for infusion 400mg/16ml
(bevacizumab biosimilar)

HK-09628-AMGEN-2022-Dec
Date of Approval: Dec 2022
Previous: SUPPORT